Catherine Myers
Assistant Professor of Medicine
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Dr. Catherine Myers is an Assistant Professor of Medicine at Northwestern University Feinberg School of Medicine in the United States. Her research primarily focuses on the effects of COVID-19 in lung transplant recipients and the limitations of imaging and biochemical markers in capturing disease progression during the pandemic. With a commitment to advancing medical knowledge, she contributes significantly to the field through her recent publications.
Articles (5)
Background Postoperative atrial arrhythmia (POAA) is common after lung transplant, but data on its implications and management are limited. This study assessed POAA incidence and timing, its association with mortality and rehospitalizations, and outcomes related to postoperative beta‐blocker use. Methods We retrospectively studied 233 adult lung transplant patients at Northwestern Memorial Hospital (2014–2024) without prior atrial arrhythmia. POAA, defined as atrial fibrillation or flutter, was confirmed by ECG or ambulatory monitoring. Multivariable logistic and Cox regression models evaluated predictors and outcomes, adjusting for covariates. Results POAA occurred in 69/233 patients (29.6%) and was associated with higher mortality (HR3.09, 95%CI [1.57–6.08]). Among these, 18/69 (26.1%) developed POAA after the index hospitalization at median 216 days post‐transplant, also associated with higher mortality (HR4.37, 95%CI [1.90–10.06]). Additionally, 10/69 (14.5%) required emergency visits or hospitalization specifically for arrhythmia management, and 66.6% underwent additional rhythm control (2.9% cardioversion, 46.4% anti‐arrhythmic drug, 17.4% both). Postoperative beta‐blocker use was associated with 73% less POAA (HR0.27, 95%CI [0.09–0.80]). Conclusion POAA was common and clinically significant after lung transplant, associated with substantially higher adjusted mortality even when occurring after index hospitalization. We report for the first time that POAA was frequently associated with emergency visits or rehospitalization for arrhythmia, highlighting its clinical burden well beyond the perioperative period. Postoperative beta‐blocker use was associated with markedly less POAA, a novel finding suggesting a potential prophylactic role. Overall, these findings challenge the traditional view of POAA as benign and highlight the need for tailored, evidence‐based guidelines in this high‐risk population.
Year:
2026
Background Following lung transplant, many patients develop post-operative atrial fibrillation (AF) or atrial flutter (AFL)–collectively defined as post-operative atrial arrhythmia (POAA). While early (in-hospital) POAA is linked to increased mortality, late (post-discharge) POAA is poorly understood. Risk factors and real-world management strategies for POAA are not well characterized. We aim to evaluate POAA incidence and timing, identify risk and protective factors, and assess associations with mortality and long-term outcomes. Methods This retrospective cohort study included 233 adult lung transplant recipients at Northwestern Memorial Hospital (2014–2024), excluding those with pre-existing AF or AFL. POAA was confirmed by ECG or Holter. Adjusted logistic and Cox regressions identified predictors of POAA and mortality. Results Of 233 recipients (age 58.6±12.8y, 45.1% female), POAA occurred in 29.6% (53.6% AF, 24.6% AFL, 21.7% both). Both overall (HR4.06, 95%CI[2.21–7.46]) and late (HR3.01, 95%CI[1.39–6.53]) POAA were significantly associated with mortality. 14.5% of patients with POAA required hospital-based arrhythmia management and 66.6% underwent additional rhythm control (2.9%% DCCV, 46.4% AAD initiation, 17.4% both). Preoperative pulmonary arterial hypertension (PAH) was associated with less POAA (OR0.31, 95%CI[0.14–0.62]). Postoperative beta-blocker use was associated with 73% reduced POAA (HR0.27, 95%CI[0.09–0.80]). Conclusions This study is among the first to associate late POAA with mortality and define arrhythmia-related hospitalization rates after POAA. Postoperative beta-blockers were associated with significantly less POAA, a novel finding in lung transplant recipients. Finally, preoperative PAH’s association with less POAA might reflect reduced cardiac strain post-transplant.
Year:
2025
Lung transplantation is a life-saving therapy for end-stage lung disease but has the poorest survival among solid organ transplants. We analyzed standardized electronic health record (EHR) data from the United Network for Organ Sharing (UNOS) to predict one-, three-, and five-year survival and favorable long-term outcomes post-lung transplant. We applied two multivariate machine learning approaches, XGBoost or a tabular BERT model called EHRFormer, to data from 43,869 first-time lung transplant recipients (1987–2022). XGBoost and EHRFormer identified features that align closely with established risk factors for worse outcomes such as length of index stay, recipient age, and creatinine at the time of transplant. We developed a simple perturbation method with EHRFormer to probe in silico multivariate interactions between features that influence model prediction. Despite their attention to known risk factors, machine learning applied to EHR data collected by UNOS poorly predict one-, three-, and five-year mortality after lung transplant.
Year:
2024
Year:
2020
Year:
2020
Collaborators (6)
Bradley P. Knight
Northwestern Medicine
Nikolay Markov
Research Scholar
Sloan Kettering Institute
Alexander Misharin
Associate Professor
Northwestern University Feinberg School of Medicine
GR Scott Budinger
Professor of Medicine
Northwestern University
Krishnan Warrior
Assistant Professor of Medicine
Northwestern Medicine
Ewa Szczurek
Director
University of Warsaw
Make your next move.
Prepare your application
Review drafts before you send them.